Filing Details

Accession Number:
0001061983-20-000163
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-10-05 21:03:57
Reporting Period:
2020-10-05
Accepted Time:
2020-10-05 21:03:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1061983 Cytokinetics Inc CYTK Pharmaceutical Preparations (2834) 943291317
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1226488 T John Henderson 280 East Grand Avenue
South San Francisco CA 94080
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-10-05 1,500 $12.96 2,399 No 4 M Direct
Common Stock Disposition 2020-10-05 1,500 $30.00 899 No 4 S Direct
Common Stock Acquisiton 2020-10-05 1,500 $12.96 2,399 No 4 M Direct
Common Stock Disposition 2020-10-05 1,500 $28.00 899 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2020-10-05 1,500 $0.00 1,500 $12.96
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2020-10-05 1,500 $0.00 1,500 $12.96
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,358 2011-02-03 2021-01-03 No 4 M Direct
858 2011-02-03 2021-01-03 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 83 Indirect by Spouse
Footnotes
  1. Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on June 3, 2020.